References
- Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 1952; 40: 346
- Blix S. Studies on the fibrinolytic system in the euglobulin fraction of human plasma. Scand. J. clin. Lab. Invest. Suppl. 1961a; 58
- Blix S. Antibodies after streptokinase treatment. and their importance for repeated fibrinolytic therapy. Acta med. scand. 1961b; 170: 201
- Blix S. The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy. Acta med. scand. Suppl. 1962; 386
- Kowalski E., Kopéc M., Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J. clin. Path. 1959; 12: 215
- Lassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta physiol. scand. 1952; 27: 371
- Macfarlane R. G., Pilling J. Observations on fibrinolysis. Lancet 1946; ii: 562
- Milstone H. A factor in normal human blood which participates in streptococcal fibrinolysis. J. Immunol. 1941; 42: 109
- Nilsson I. M., BjoUrkman S. E., Andersson L. Clinical experiences with e-aminocaproic acid as an antifibrinolytic agent. Acta med. scand. 1961; 170: 487
- Olow B., Nilsson I. M. Streptokinase induced fibrinolysis in man. Proc. 8th Congr. europ. Soc. Haemat., Vienna 1961. S. Karger. 1962; 444, Basel II
- Owren P. A. The coagulation of blood. Acta med. scand. Suppl. 1947; 194
- Reinskou T. 1962, Personal communication